Early Enteral Nutrition and Clinical Outcomes in Critically Ill Pediatric Populations: A Systematic Review and

Nicole Gilbert1,2, Emma Schalm3, Krista Wollny4

  • 1Nutrition Services, Alberta Health Services, Calgary, AB, Canada.

Critical Care Medicine
|September 17, 2025
PubMed

Insights

Early enteral nutrition (EEN) in critically ill children is linked to better outcomes, including reduced mortality. However, the evidence quality is very low due to study limitations.

Area of Science:

  • Pediatric critical care medicine
  • Clinical nutrition
  • Evidence-based medicine

Background:

  • Current guidelines advocate for early enteral nutrition (EEN) in critically ill children.
  • The clinical benefits and potential risks of EEN require further investigation, especially when adjusted for illness severity.

Purpose of the Study:

  • To determine if EEN in critically ill children is associated with improved clinical outcomes compared to delayed enteral nutrition (DEN).
  • Prioritize associations adjusted for illness severity to provide reliable evidence.

Main Methods:

  • A systematic review and meta-analysis of randomized control trials (RCTs), quasi-experimental, observational cohort, and case-control studies.
  • Searched MEDLINE, Embase, CINAHL, and CENTRAL databases up to October 2024.
  • Data extraction and risk of bias assessment were performed by two independent reviewers.

Main Results:

  • Meta-analysis of 13 studies (1 RCT, 12 cohort) showed EEN was associated with reduced mortality when adjusted for illness severity (aOR 0.36; 95% CI, 0.14-0.91).
  • Qualitative review of 18 studies (n=9829) indicated EEN was associated with shorter hospital stays, reduced respiratory support, improved nutritional adequacy, and fewer infections.
  • No harmful effects of EEN were identified after adjusting for confounding variables.

Conclusions:

  • EEN is associated with beneficial clinical outcomes in critically ill children.
  • The certainty of evidence is very low due to the predominance of cohort studies with limited confounding adjustment, study heterogeneity, and small sample sizes.
  • Further high-quality research is needed to confirm these findings.
Abstract

Related Concept Videos

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
853
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
1.3K
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
773
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
246
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
254
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
195